The U.S. Food and Drug Administration (FDA) recently published its response to three citizen petitions and its draft Guidance for Industry relating to the determination of the five-year new chemical entity (NCE) exclusivity for fixed-combination...
By: Duane Morris LLP
By: Duane Morris LLP